scispace - formally typeset
C

Carlos Roncero

Researcher at University of Salamanca

Publications -  222
Citations -  3474

Carlos Roncero is an academic researcher from University of Salamanca. The author has contributed to research in topics: Dual diagnosis & Comorbidity. The author has an hindex of 28, co-authored 212 publications receiving 2759 citations. Previous affiliations of Carlos Roncero include American Board of Legal Medicine & Complutense University of Madrid.

Papers
More filters
Reference EntryDOI

Efficacy of Psychostimulant Drugs for Cocaine Dependence

TL;DR: Evidence of the efficacy of psychostimulants for cocaine dependence is inconclusive, however promising results exist for methadone maintained dual heroin-cocaine addicts and for some specific drugs such as dexamphetamine and bupropion.
Journal ArticleDOI

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

TL;DR: Findings have implications for meeting WHO targets, with evidence of some countries not following the 2016 hepatitis C virus treatment guidelines by the European Association for the Study of Liver.
Posted ContentDOI

Anxiety, worry and perceived stress in the world due to the COVID-19 pandemic, March 2020. Preliminary results

TL;DR: This survey is the first attempt to measure the psychological consequences this pandemic is having, in order to be able to provide the support to confront this global issue, addressing the mental health care that will be needed.
Journal Article

Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders.

TL;DR: ASRS-v1.1 is a simple screening tool that is useful and has acceptable validity for the identification of ADHD among addicted patients and it is indicated that 20% of patients evaluated meet the criteria for ADHD.
Journal ArticleDOI

Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction.

TL;DR: In this paper, the authors considered the contribution of brain-derived neurotrophic factor (BDNF) and its main intracellular signaling mechanisms, including mitogen-activated protein kinase/extracellular signal-regulated protein kinases (MAPK/ERK) and phosphatidylinositol 3-kinase (PI3K), in psychostimulant addiction.